Angiodynamics released FY2025 9 Months Earnings on April 2 Pre-Market EST, with actual revenue of 212.34 M USD and EPS of -0.6872 USD
Brief Summary
Angiodynamics reported its fiscal 2025 third-quarter revenue of $212.34 million and EPS of -0.6872, which contrasts with additional metrics like adjusted net income of -$4.4 million and sales of $72 million as indicated in other reports Reuters+ 2.
Impact of The News
The financial briefing from Angiodynamics highlights several key financial indicators that shed light on the company’s current standing and potential future trajectory:
Revenue and Profit Figures: The company reported revenues of $212.34 million and a net loss of $27.943 million for the third quarter, translating to an earnings per share (EPS) of -0.6872 Reuters+ 2. This loss is notably larger than the adjusted net income loss of $4.4 million and the sales of $72 million, suggesting discrepancies in accounting adjustments or sector-specific challenges Reuters+ 2.
Comparison to Peer Benchmarks: The third quarter’s revenue decreased by 4% compared to the same period last year, indicating potential market challenges or shifts in demand Alpha Street. Despite these numbers, the company maintains a high gross margin of 54%, which can be a competitive advantage in cost management or product pricing strategy Reuters.
Market Expectations and Business Status: Although specifics on market expectations aren’t provided, the significant loss and revenue decline could imply a miss in expectations, impacting investor sentiment negatively. The company projects fiscal year 2025 sales to be between $285 million and $288 million, which suggests anticipated growth and recovery strategies Alpha Street.
Future Business Development Trends: Despite the current challenges, Angiodynamics continues to see robust growth in its Auryon revenue stream, marking the 15th consecutive quarter of double-digit growth . This indicates a strong potential for future revenue stabilization and growth, particularly if strategic investments in high-growth areas continue.
Overall, these figures suggest a period of financial strain but with underlying strengths and strategic plans that may support future stabilization and growth.
